New international study shows women with symptomatic fibroids delaying treatment despite substantial burden on quality of life | Medicexchange News
LinkedIn Login

Connect healthcare products, companies and hospitals with your LinkedIn network.

Facebook Login

Interact with your Facebook network around healthcare products, companies and hospitals.

Login With Facebook
MedicExchange Login

Enjoy Premium Access as a MedicExchange Member.

       Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Facebook Twitter Linkedin
Facebook: MedicExchange
Twitter: MedicExchange

New international study shows women with symptomatic fibroids delaying treatment despite substantial burden on quality of life

Medicexchange News - Medicexchange News
ETHICON Women's Health & Urology has announced results of a seven-country study measuring the effects of uterine fibroids and associated symptoms on quality of life.

At the annual meeting of the American Association of Gynecologic Laparoscopists (AAGL), ETHICON Women's Health & Urology today announced results of a seven-country study measuring the effects of uterine fibroids and associated symptoms on quality of life (QoL). Researchers found that one in five women suffer with symptomatic fibroids for more than five years before getting medical treatment. Further, despite diagnosis, more than one-third of women remain untreated - either surgically or medically - for their fibroids, which means that many women continue to experience symptoms severe enough to affect QoL.

Uterine fibroids are benign tumors made up of fibrous and muscular tissue in the uterine wall. They occur in one third of women over age thirty and are a major reason for hysterectomy worldwide. Women who have uterine fibroids may experience debilitating symptoms such as abnormal bleeding, pain, pressure in the pelvic region, painful intercourse, frequent urination or infertility.

The CHASM (Cross-Sectional Survey of HRQoL And Symptoms of Myoma) study was sponsored by ETHICON and designed to quantify the fibroid burden on a woman's QoL and to better understand current management of symptomatic fibroids. More than 2,500 adult women experiencing fibroid symptoms with a self-reported physician diagnosis or previous treatment for uterine fibroids were surveyed in the United States, Canada and five European countries. Researchers found that:

  •   Overall, 22 per cent of women who have been diagnosed with uterine fibroids
          waited at least five years before getting treatment.
  • A substantial percentage of women (almost 45 per cent of those diagnosed and
          almost 70 per cent of those with symptoms) have not sought any treatment in
          the past year
  • Of those who have sought medical care and been diagnosed, more than
          36 per cent have not received surgical or medical treatment, despite reporting
          symptoms that interfere with their quality of life
  • Women who have opted for surgical treatment report a better quality of
          life outcome than those who have used medication